Delivery Order SPE2DR25D2005-SPE2DR26FE8B9
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,206.04 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a $10,274.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes. The contract, with an ultimate completion date of November 5, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dupixent 300 mg/2 ml syringes valued at $37,286.90 with a completion date of December 10, 2025. This competitive, non-set-aside contract utilizes firm fixed price pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $27,437.03 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is set to be completed by December 3, 2025, with performance at the vendor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,840.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This firm fixed price, competitively awarded delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $79,034.62 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 9, 2025, for the supply of Dupixent 300 mg/2 ml syringes. The contract, valued at $3,676.08 with firm fixed pricing, is scheduled for completion by December 10, 2025, and represents a non-competitive, non-set-aside award. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,050.45 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on December 3, 2025, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price contract represents a pediatric or adult pharmaceutical delivery under DLA's medical supply chain operations. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,569.78 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on November 14, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,404.59 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. The contract utilizes firm fixed price pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...